Other and unspecified primary disorders of muscles

G6_MUSCOTHUNS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

264

4. Check minimum number of events

None

264

5. Include endpoints

None

264

6. Filter based on genotype QC (FinnGen only)

264

Control definitions (FinnGen only)

Control exclude
G6_MYONEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1716 804 901
Only index persons 1507 719 788
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 51.52 52.43 50.70
Only index persons 51.61 52.14 51.12

-FinnGen-

Key figures

All Female Male
Number of individuals 264 137 127
Unadjusted period prevalence (%) 0.05 0.05 0.06
Median age at first event (years) 51.61 51.78 51.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
242
Matched controls
2421
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
210.3
170
*
G71.8
ICD-10 Finland
Other primary disorders of muscles
+∞
103.8
92
*
G72.9
ICD-10 Finland
Myopathy, unspecified
593.0
84.6
79
*
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
64.5
59
*
G71.18
ICD-10 Finland
Other myotonic disease
+∞
34.2
32
*
R1250
NOMESCO Finland
Evaluation of functional capability
30.6
30.9
41
16
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
118.0
29.4
31
*
NXL00
NOMESCO Finland
Biopsy of muscle
73.3
28.7
32
5
Z31.5
ICD-10 Finland
Genetic counselling
10.8
27.4
55
64
G72.8
ICD-10 Finland
Other specified myopathies
+∞
24.4
23
*
L28
ICPC
Limited function/disability (L)
5.1
19.8
70
179
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.4
19.3
54
104
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
19.0
18
*
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
+∞
19.0
18
*
N03AE01
ATC
clonazepam; systemic
7.4
17.4
43
69
M60.8
ICD-10 Finland
Other myositis
+∞
16.9
16
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
7.4
16.7
41
65
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
43.4
16.6
20
5
SPAT1229
SPAT
Assessment of need for aid
6.2
14.8
41
77
G71.0
ICD-10 Finland
Muscular dystrophy
+∞
14.7
14
*
G71.11
ICD-10 Finland
Dystrophia myotonica [Steinert]
+∞
14.7
14
*
J96.1
ICD-10 Finland
Chronic respiratory failure
17.2
14.2
22
14
N99
ICPC
Neurological disease other
32.2
14.1
18
6
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
79.8
13.7
15
*
G71.12
ICD-10 Finland
Myotonia congenita
+∞
13.7
13
*
M60.9
ICD-10 Finland
Myositis, unspecified
53.0
13.0
15
*
N18
ICPC
Paralysis/weakness
21.5
12.7
18
9
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
12.6
53
156
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
11.4
12.0
22
21
C10AX09
ATC
ezetimibe; oral
4.7
12.0
42
103
Z3226
NOMESCO Finland
Physiotherapist
3.2
12.0
73
288
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
68.4
11.7
13
*
G71.06
ICD-10 Finland
Muscular dystrophy severe [Duchenne]
+∞
11.5
11
*
R4120
NOMESCO Finland
Occupational therapy
5.4
11.4
35
74
L99
ICPC
Musculoskeletal disease other
16.5
11.0
17
11
R13
ICD-10 Finland
Dysphagia
5.3
10.8
33
70
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.3
10.6
40
106
M33.2
ICD-10 Finland
Polymyositis
114.8
10.5
11
*
N28
ICPC
Limited function/disability (N)
17.0
10.5
16
10
G71.28
ICD-10 Finland
Other congenital myopathy
+∞
10.5
10
*
N03AX12
ATC
gabapentin; oral
3.5
10.1
50
168
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.2
9.9
58
219
R4110
NOMESCO Finland
Physiotherapy
2.7
9.9
86
416
N29
ICPC
Neurological sympt/complt other
14.2
9.8
16
12
XF404
NOMESCO Finland
Ambulatory ECG
4.2
9.8
38
103
N03AX16
ATC
pregabalin; oral
2.8
9.7
73
325
G71.25
ICD-10 Finland
Congenital muscular dystrophy NOS
+∞
9.4
9
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
9.3
81
389
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
14.4
9.3
15
11
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.0
8.8
35
97
N07AA02
ATC
pyridostigmine; systemic
51.9
8.7
10
*
N03AF01
ATC
carbamazepine; oral, rectal
6.1
8.7
23
41
L19
ICPC
Muscle symptom/complaint NOS
9.5
8.7
17
19
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
93.2
8.5
9
*
33030
ICD-8 Finland
Hereditary neuromuscular disorders, Progressive muscular dystrophy
+∞
8.4
8
*
M03BX01
ATC
baclofen; systemic
15.2
8.3
13
9
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
8.3
64
285
Z50.1
ICD-10 Finland
Other physical therapy
4.9
8.2
26
58
RF410
NOMESCO Finland
NA
34.6
8.1
10
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.2
8.1
30
78
A28
ICPC
Limited function/disability NOS
3.2
8.1
44
156
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
7.8
52
213
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
46.5
7.8
9
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
7.6
38
128
XA402
NOMESCO Finland
ENMG
8.1
7.5
16
21
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
82.5
7.5
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
7.5
38
130
33098
ICD-8 Finland
Hereditary neuromuscular disorders, Alii definiti
+∞
7.3
7
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
7.3
7
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
7.3
7
*
3591A
ICD-9 Finland
Muscular dystrophies and other myopathies, Hereditary progressive muscular dystrophy
+∞
7.3
7
*
R06.0
ICD-10 Finland
Dyspnoea
2.4
7.3
68
335
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
31.0
7.2
9
*
G47.3
ICD-10 Finland
Sleep apnoea
2.5
7.2
63
301
H02AB06
ATC
prednisolone; systemic
2.1
7.1
121
784
R52.2
ICD-10 Finland
Other chronic pain
5.1
7.0
21
44
RF420
NOMESCO Finland
NA
14.3
7.0
11
8
JDB10
NOMESCO Finland
Percutaneous gastrostomy
14.3
7.0
11
8
SPAT1231
SPAT
Assessment of adjustments needed in living environment
9.7
6.9
13
14
N06AX21
ATC
duloxetine; oral
3.3
6.8
33
109
RF120
NOMESCO Finland
NA
17.3
6.8
10
6
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
6.8
28
81
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.0
6.6
25
67
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
6.5
95
569
ZX120
NOMESCO Finland
Intravenous
3.1
6.3
35
125
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.3
6.3
18
36
TJD20
NOMESCO Finland
Change of gastrostomy tube
18.6
6.3
9
5
3599X
ICD-9 Finland
Muscular dystrophies and other myopathies, Myopathy, unspecified
+∞
6.3
6
*
SPAT1216
SPAT
Assessment of functional ability
2.7
6.0
41
169

Mortality – FinRegistry

Association

Association between endpoint G6_MUSCOTHUNS and mortality.

Females

Parameter HR [95% CI] p-value
G6_MUSCOTHUNS 2.962 [2.19, 4.0] < 0.001
Birth year 0.992 [0.98, 1.0] 0.081

During the follow-up period (1.1.1998 — 31.12.2019), 136 out of 719 females with G6_MUSCOTHUNS died.

Males

Parameter HR [95% CI] p-value
G6_MUSCOTHUNS 2.651 [2.11, 3.34] < 0.001
Birth year 0.987 [0.98, 1.0] 0.024

During the follow-up period (1.1.1998 — 31.12.2019), 181 out of 773 males with G6_MUSCOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MUSCOTHUNS.

N-year risk Females Males
1 0.252% 0.384%
5 1.66% 2.69%
10 3.948% 6.826%
15 7.418% 13.381%
20 12.42% 22.845%

Relationships between endpoints

Index endpoint: G6_MUSCOTHUNS – Other and unspecified primary disorders of muscles

GWS hits: 9

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data